Karyopharm Therapeutics (KPTI) PT Lowered to $14 at Wedbush

Go back to Karyopharm Therapeutics (KPTI) PT Lowered to $14 at Wedbush

Karyopharm Therapeutics (KPTI) Announces Michael P. Mason as SVP, CFO and Treasurer

February 25, 2019 7:08 AM EST

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) today announced the appointment of Michael P. Mason as Senior Vice President, Chief Financial Officer and Treasurer. In this role, Mr. Mason will be responsible for leading and directing the financial activities of the Company.

Mr. Mason brings to Karyopharm more than 18 years of diversified financial experience in executing financial strategies and leading growth initiatives for life sciences companies. Most recently,... More